Arch Biopartners Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Arch Biopartners Inc with three other
companies in this sector in Canada:
Novoheart Holdings Inc
sales of 11,876.00 Canadian Dollars [US$9,321.83 ]
Pacgen Life Science Corporation
(59,552.00 Canadian Dollars [US$46,744.15 ]
Promis Neurosciences Inc
(19,935.00 Canadian Dollars [US$15,647.58 ]
of which 100%
was Research and Develo).